Ptc Therapeutics reported $257.89M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 168.21M 60.27M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Amgen AMGN:US $ 4.42B 680M
Biocryst Pharmaceuticals BCRX:US $ 100.25M 374K
Biogen BIIB:US $ 2648.2M 727.1M
Biomarin Pharmaceutical BMRN:US $ 494.65M 112.61M
Bluebird Bio BLUE:US $ 108.92M 13.37M
Cytokinetics CYTK:US $ 99.84M 18.14M
Daiichi Sankyo 4568:JP 245.94B 38.74B
Enanta Pharmaceuticals ENTA:US $ 52.02M 544K
Esperion Therapeutics ESPR:US $ 71.22M 9.39M
Gilead Sciences GILD:US $ 4231M 2162M
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
IONIS PHARMACEUT IONS:US $ 219.3M 19.88M
Ironwood Pharmaceuticals IRWD:US $ 41.58M 1.89M
Karyopharm Therapeutics KPTI:US $ 82.59M 331K
Novartis NOVN:VX 10.86B 895M
Pfizer PFE:US $ 15640M 148M
Ptc Therapeutics PTCT:US $ 257.89M 22.63M
Puma Biotechnology PBYI:US $ 47.52M 1.01M
Sangamo Biosciences SGMO:US $ 75.11M 1.62M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Tg Therapeutics TGTX:US $ 39.53M 29.35M
Ultragenyx Pharmaceutical RARE:US $ 230.94M 14.37M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
Xencor XNCR:US $ 58.18M 854K
YTE INCY:US $ 656.97M 40.27M